
View larger version (116K):
[in this window]
[in a new window]
|
Fig. 6. Src activates E-cadherin transcription through Arm. (A-C)
Control; (D-F) btl>Src42AACT;
(G,H) Src42Amyr; (I)
btl>TCF N; (J,K)
btl>TCF N+Src42AACT;
(L,M) btl>wg. Tracheal cells are labeled with
btl>GFP-moesin (green). (A,D,G) Arm (grayscale) is localized to
the apical cell-cell junction in control embryos (A). In
Src42AACT embryos, the Arm signal increased to fill the
entire tracheal cell (D). Arm staining was reduced in Src42A mutants
(G). (B,E,H,J,L) Esg expression (magenta) was localized to fusion cells in
control embryos (B), and the number of Esg-expressing cells was greatly
increased in embryos overexpressing Src42AACT or
wg (E,L). In Src42Amyr or
Src42AACT, TCF N embryos, Esg was almost
undetectable (H,J). (C,F,I,K,M) shg-lacZ (nuclear signal, magenta)
was broadly expressed, with elevated levels in tracheal fusion cells (C,
asterisk in C'). (C'-M') Framed area in C-M enlarged and shown in
grayscale. The number of strong shg-lacZ-expressing cells increased
in embryos overexpressing Src42AACT or wg (F,M).
In Src42Amyr or Src42AACT,
TCF N embryos, shg-lacZ expression was reduced in
tracheal cells (I,K; compare the levels in the trachea and ectoderm). Scale
bar in A: 20 µm for A-M. (N) RNA quantification.
Src42AACT, Src42AGS or wg was
expressed under the control of the ubiquitous da-Gal4 driver, and the
levels of E-cadherin, arm and rac1 mRNAs were measured by
quantitative RT-PCR. da-Gal4 embryos were used as a control.
|